A screenshot of a patient profile page from the Exalgo Hydromorphone HCI Patient Profile. The page is titled "She's asking the same of her pain medication. Maybe it's time to switch opioids."

The page has a white background with black text. On the left side of the page there is a title that reads "In the pivotal trial switching to EXALGO provided long-lasting pain relief to successfully converted patients compared to placebo." Below the title there are two graphs. The first graph is a line graph that shows the percentage of patients who have been diagnosed with pain medication with the x-axis representing the time period and the y-axis indicating the number of patients.

On the right side of this page it has a section titled "Sustained Pain Scores in Double-blind Treatment Phase" which explains that the patient has sustained pain scores in double-blind treatment phases. The graph shows a decrease in pain scores over time with a slight increase in the percentage. There is also a section labeled "See additional risk information including full-boxed warning and full-prescription information by selecting their icons below."

At the bottom right corner of the image there has a logo for Eagle a company that provides information about the patient profile.

• Advertisement

• Sales and Marketing